Titan Medical (TMDI) and Irhythm Technologies (IRTC) Critical Review

Titan Medical (NASDAQ:TMDI) and Irhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, profitability, dividends, earnings, valuation and institutional ownership.

Earnings and Valuation

This table compares Titan Medical and Irhythm Technologies’ gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Titan Medical N/A N/A N/A N/A N/A
Irhythm Technologies $98.51 million 21.06 -$29.42 million ($1.30) -66.65

Titan Medical has higher earnings, but lower revenue than Irhythm Technologies.

Analyst Ratings

This is a summary of recent ratings and target prices for Titan Medical and Irhythm Technologies, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Titan Medical 0 0 3 0 3.00
Irhythm Technologies 0 3 6 0 2.67

Titan Medical presently has a consensus target price of $6.67, indicating a potential upside of 200.30%. Irhythm Technologies has a consensus target price of $94.14, indicating a potential upside of 8.66%. Given Titan Medical’s stronger consensus rating and higher possible upside, equities analysts plainly believe Titan Medical is more favorable than Irhythm Technologies.

Institutional & Insider Ownership

0.5% of Titan Medical shares are held by institutional investors. 5.1% of Irhythm Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Titan Medical and Irhythm Technologies’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Titan Medical N/A N/A N/A
Irhythm Technologies -34.38% -53.59% -32.15%

Summary

Titan Medical beats Irhythm Technologies on 6 of the 9 factors compared between the two stocks.

About Titan Medical

Titan Medical Inc., a development stage company, focuses on design and development of robotic surgical system for application in minimally invasive surgery (MIS). The company is developing SPORT Surgical System, a single-port robotic surgical system that comprises a surgeon-controlled patient cart, which includes a 3D vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. The SPORT Surgical System enables surgeons to perform various surgical procedures for general abdominal, gynecologic, urologic, and colorectal indications. The company is headquartered in Toronto, Canada.

About Irhythm Technologies

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. Its Zio XT monitor, a single-use, wire-free, and wearable patch-based biosensor, records patient's heartbeats and ECG data. The company was founded in 2006 and is headquartered in San Francisco, California.

Receive News & Ratings for Titan Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply